Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.
- DOI
- 10.1016/s0149-2918(98)80055-6
- Published
- 1998 May-Jun
- Container
- Clinical therapeutics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s0149-2918-98-80055-6,
title = {Comparison of the efficacy and safety of 2\% dorzolamide and 0.5\% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.},
author = {Rusk C and Sharpe E and Laurence J and Polis A and Adamsons I},
year = {1998},
journal = {Clinical therapeutics},
doi = {10.1016/s0149-2918(98)80055-6},
url = {https://doi.org/10.1016/s0149-2918(98)80055-6}
}RIS
TY - JOUR TI - Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group. AU - Rusk C AU - Sharpe E AU - Laurence J AU - Polis A AU - Adamsons I PY - 1998 JO - Clinical therapeutics DO - 10.1016/s0149-2918(98)80055-6 UR - https://doi.org/10.1016/s0149-2918(98)80055-6 ER -
APA
C, R., E, S., J, L., A, P., & I, A. (1998). Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.. Clinical therapeutics. https://doi.org/10.1016/s0149-2918(98)80055-6
Source records
- pubmed · retrieved 2026-09-26T12:34:55.268Z